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Background
There are a number of monoclonal antibodies possessing
neutralizing activity against the broad range of HIV-1 iso-
lates. Some of them recognize conformational epitopes of
HIV-1 antigens. Obviously, artificial anti-HIV polyepitope
vaccines should induce a necessary spectrum of broadly
neutralizing antibodies. Polyepitope TBI protein contain-
ing 4 T-cellular and 5 B-cellular linear epitopes from Env
and Gag proteins of HIV-1 has been created earlier. Three
linear peptides imitating natural HIV-1 conformational
2G12-determinant were selected using phage display and
inserted in TBI.
The aim of our work was to study antigenic properties of
these mimotopes in the context of newly created TBIs
(TBI-1, TBI-2, and TBI-3).
Methods
Phage display was used to select peptides mimicking a
HIV-1 gp120 conformational epitope recognized by neu-
tralizing mAb 2G12.
Three linear antigenic determinants were found as a result
of three rounds of biopanning. Oligonucleotides coding
for these peptides-mimotopes were inserted into the TBI
gene. Derivatives of TBI protein (TBI-1, TBI-2, TBI-3) con-
taining mimotopes were expressed in E. coli and character-
ized by Western-blot and ELISA. Mice Balb/c were
immunized by these recombinant proteins.
Results
The newly created TBIs were shown to react in ELISA and
Western-blot with 2G12 mAb, which means that they
maintain original antigenic features of selected mimo-
topes. The sera of immunized animals recognise in ELISA
both peptides-mimotopes for 2G12 as well as native HIV-
1 antigen. The study of virus-neutralising activity of sera
obtained is planning in the nearest future.
Conclusion
The selected peptides imitating natural epitopes for 2G12
mAb may be proposed as components of polyepitope
anti-HIV vaccine.
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